Fund Tracker India by Ishaan Dungarwal
Guide

Which mutual funds hold Q-Line Biotech Limited?

1 fund houses holding · net +85,200 shares (+0.37 pp of equity) · Oct 2026 vs Sep 2026

1 fund houses holding · net +85,200 shares (+0.37 pp of equity) · Oct 2026 vs Sep 2026

Net bought by the tracked fund houses 3 months in a row, Aug 2026 to Oct 2026 (share count, each month against the one before; houses with both months, index and arbitrage funds left out).

% of equity, Oct 2026 Activity Source
Abakkus Mutual Fund 1 5.14 lakh2.20% 5.99 lakh2.57% ▲ +85,200▲ +0.37 pp 2.57% Added bought 3 months in a row Disclosure ↗
Abakkus Mutual Fund 1 5.14 lakh2.20% 5.99 lakh2.57% ▲ +85,200▲ +0.37 pp 2.57% Added Disclosure ↗
Source: each AMC's SEBI monthly portfolio disclosure, Oct 2026. Report a wrong number

Shares as disclosed; % of equity uses 2.33 cr shares outstanding (NSE, 20 Nov 2026) for both months. "Not compared" = the fund house has no Sep 2026 portfolio.

Schemes holding QLINE, Oct 2026 (1)

largest holding first
SchemeFund houseShares% of schemeRank in scheme% of scheme vs Jul 2026Shares vs Jul 2026Months in a row
Abakkus Small Cap FundAbakkus Mutual Fund5.99 lakh0.92%56 of 64 (was 53)−0.32 pp+1.14 lakhbought 3 months in a row
Source: each AMC's SEBI monthly portfolio disclosure, Oct 2026 and Jul 2026. Report a wrong number

Index and arbitrage schemes included. Rank: by value among the scheme's equity holdings (1 = largest). Jul 2026: the same scheme's portfolio three months before; shares in Oct 2026's units (split or bonus adjusted). Months in a row: months the scheme's share count went up (bought) or down (sold), each month against the one before.